{
    "title": "Regeneron starts COVID-19 antibody cocktail late-stage trials, shares rise",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8494101/Regeneron-begins-COVID-19-antibody-cocktail-late-stage-trial.html",
    "date": "2020-07-06",
    "keywords": [
        "covid19",
        "antibody",
        "trisha",
        "roy",
        "effectiveness",
        "cocktail",
        "ability",
        "therapy",
        "drugmaker",
        "july",
        "monday",
        "institute",
        "allergy",
        "regncov2s",
        "infection",
        "exposure",
        "patient",
        "trial",
        "review",
        "data",
        "monitoring",
        "committee",
        "earlystage",
        "safety",
        "stage",
        "phase",
        "summer",
        "testing",
        "june",
        "regeneron",
        "analyst",
        "robyn",
        "regncov2",
        "hospitalization",
        "spread",
        "morning",
        "trading",
        "bell",
        "combination",
        "company",
        "coronavirus",
        "spike",
        "protein",
        "drug",
        "kevzara",
        "sanofi",
        "thursday",
        "goal",
        "study",
        "sibi",
        "joseph",
        "bengaluru",
        "editing",
        "shinjini",
        "ganguli"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}